| Income Statement | Dec2016 | Dec2017 | Dec2019 | Dec2020 | Dec2021 | Dec2022 | Dec2023 | Dec2024 | Dec2025 |
|---|---|---|---|---|---|---|---|---|---|
| Operating items | |||||||||
| Research & Development (Quarter) | 166.00M | ||||||||
| Operating Expenses (Quarter) | 166.00M | ||||||||
| Net income details | |||||||||
| Equity Income (Quarter) | -166.00M | ||||||||
| Additional items | |||||||||
| Shares Outstanding (Weighted Average) (Quarter) | 1,155.99M | 1,179.54M | 1,184.55M | 1,163.99M | 1,142.04M | 1,100.52M | 1,051.69M | 995.47M |